Ozempic cuts risk of death from kidney disease, major study finds
Novo Nordisk, the maker of Ozempic will seek FDA approval to dramatically expand the number of patients eligible for the shots.
Source: pressherald.com
📰 Michael Radin News
Michael Radin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Radin. Real-time updates on events, politics, business and more.